- Home
- THCH vs FBIO Comparison
THCH vs FBIO Comparison
Compare THCH & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- FBIO
- Stock Information
- Founded
- THCH 2018
- FBIO 2006
- Country
- THCH China
- FBIO United States
- Employees
- THCH N/A
- FBIO N/A
- Industry
- THCH Blank Checks
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- FBIO Health Care
- Exchange
- THCH Nasdaq
- FBIO Nasdaq
- Market Cap
- THCH 85.5M
- FBIO 88.7M
- IPO Year
- THCH N/A
- FBIO N/A
- Fundamental
- Price
- THCH $2.67
- FBIO $2.70
- Analyst Decision
- THCH
- FBIO Strong Buy
- Analyst Count
- THCH 0
- FBIO 2
- Target Price
- THCH N/A
- FBIO $16.50
- AVG Volume (30 Days)
- THCH 9.1K
- FBIO 393.8K
- Earning Date
- THCH 11-12-2025
- FBIO 11-12-2025
- Dividend Yield
- THCH N/A
- FBIO N/A
- EPS Growth
- THCH N/A
- FBIO N/A
- EPS
- THCH N/A
- FBIO N/A
- Revenue
- THCH $187,316,342.00
- FBIO $59,301,000.00
- Revenue This Year
- THCH N/A
- FBIO $31.85
- Revenue Next Year
- THCH N/A
- FBIO $44.43
- P/E Ratio
- THCH N/A
- FBIO N/A
- Revenue Growth
- THCH N/A
- FBIO N/A
- 52 Week Low
- THCH $1.95
- FBIO $1.33
- 52 Week High
- THCH $5.15
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- THCH 53.57
- FBIO 50.08
- Support Level
- THCH $2.50
- FBIO $2.39
- Resistance Level
- THCH $2.76
- FBIO $2.65
- Average True Range (ATR)
- THCH 0.15
- FBIO 0.12
- MACD
- THCH 0.01
- FBIO 0.03
- Stochastic Oscillator
- THCH 30.00
- FBIO 94.03
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.